Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:12:04.608Z.
Calculation as of: 2026-10-06T14:12:04.608Z.
Quote observation: 2026-10-06T14:10:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5aadd97284981d173c87413c67de95801d58f7ce8cc73935cbfc70b12a62615a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Generate Biomedicines, Inc.
Market Cap
$1.75B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.75B
Free Cash Flow Yield
N/A
TTM Avg
8.65%
3Y Avg
8.65%
5Y Avg
8.65%
Market Cap
$1.73B
Free Cash Flow Yield
8.26%
TTM Avg
4.66%
3Y Avg
5.81%
5Y Avg
5.68%
Market Cap
$1.71B
Free Cash Flow Yield
N/A
TTM Avg
0.77%
3Y Avg
2.10%
5Y Avg
2.10%
Market Cap
$1.84B
Free Cash Flow Yield
4.02%
TTM Avg
3.25%
3Y Avg
2.36%
5Y Avg
2.43%
Market Cap
$1.84B
Free Cash Flow Yield
8.62%
TTM Avg
8.12%
3Y Avg
5.35%
5Y Avg
4.67%
Market Cap
$1.65B
Free Cash Flow Yield
0.25%
TTM Avg
0.34%
3Y Avg
0.34%
5Y Avg
0.34%
Market Cap
$1.65B
Free Cash Flow Yield
N/A
TTM Avg
7.59%
3Y Avg
6.29%
5Y Avg
6.29%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.75B | N/A | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.75B | N/A | 8.65% | 8.65% | 8.65% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 8.26% | 4.66% | 5.81% | 5.68% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.71B | N/A | 0.77% | 2.10% | 2.10% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.84B | 4.02% | 3.25% | 2.36% | 2.43% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 8.62% | 8.12% | 5.35% | 4.67% |
| Absci Corporation (ABSI)vs › | $1.84B | N/A | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 0.25% | 0.34% | 0.34% | 0.34% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | N/A | 7.59% | 6.29% | 6.29% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.65B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
